A carregar...
Development of Intranasal Levothyroxine Powder Delivery for Hypothyroidism
Background: Hypothyroidism affects 3-5% of the general population with oral levothyroxine (LT4) being the predominant replacement therapy. However, significant proportion of hypothyroid patients are unable to absorb oral replacement leading to therapeutic failure and may require injectable thyroxine...
Na minha lista:
| Publicado no: | J Endocr Soc |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Oxford University Press
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8089816/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jendso/bvab048.1689 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|